title: Barbiturates are selective antagonists at A1 adenosine receptors.
abstract: Barbiturates in pharmacologically relevant concentrations inhibit binding of (R)-N6-phenylisopropyl[3H]adenosine ([3H]PIA) to solubilized A1 adenosine receptors in a concentration-dependent, stereospecific, and competitive manner. Ki values are similar to those obtained for membrane-bound receptors and are 31 microM for (+/-)-5-(1,3-dimethyl)-5-ethylbarbituric acid [(+/-)-DMBB] and 89 microM for (+/-)-pentobarbital. Kinetic experiments demonstrate that barbiturates compete directly for the binding site of the receptor. The inhibition of rat striatal adenylate cyclase by unlabelled (R)-N6-phenylisopropyladenosine [(R)-PIA] is antagonized by barbiturates in the same concentrations that inhibit radioligand binding. The stimulation of adenylate cyclase via A2 adenosine receptors in membranes from N1E 115 neuroblastoma cells is antagonized only by 10-30 times higher concentrations of barbiturates. It is concluded that barbiturates are selective antagonists at the A1 receptor subtype. In analogy to the excitatory effects of methylxanthines it is suggested that A1 adenosine receptor antagonism may convey excitatory properties to barbiturates.
mesh_terms: D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D001463:Barbiturates / Q000494:pharmacology*; D002460:Cell Line; D003342:Corpus Striatum / Q000201:enzymology / Q000378:metabolism; D006801:Humans; D008297:Male; D009447:Neuroblastoma / Q000201:enzymology / Q000378:metabolism; D010634:Phenobarbital / Q000031:analogs & derivatives / Q000494:pharmacology; D010660:Phenylisopropyladenosine / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D011956:Receptors, Cell Surface / Q000037:antagonists & inhibitors* / Q000378:metabolism; D011963:Receptors, GABA-A / Q000378:metabolism; D011983:Receptors, Purinergic; D013329:Structure-Activity Relationship
chemical_list: D001463:Barbiturates; D011956:Receptors, Cell Surface; D011963:Receptors, GABA-A; D011983:Receptors, Purinergic; D010660:Phenylisopropyladenosine; C008555:1-methyl-5-phenyl-5-propylbarbituric acid; D000262:Adenylyl Cyclases; D010634:Phenobarbital